Petlife Pharmaceuticals Inc PTLF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.25
- Market Cap
- $19,675.17
- Volume/Avg
- 1,000 / 30,338
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 1
- Website
- http://www.petlifepharma.com
Valuation
|
Metric
|
PTLF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
PTLF
Financial Strength
|
Metric
|
PTLF
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | −5.88 |
Quick Ratio
PTLF
Profitability
|
Metric
|
PTLF
|
|---|---|
Return on Assets (Normalized) | −1,366.31% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
PTLF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Hwslfztgn | Ldpj | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Qcwwgmbm | Tcckwqm | $70.8 Bil | |
HLN
| Haleon PLC ADR | Xvkdqkkm | Tvfs | $38.2 Bil | |
VTRS
| Viatris Inc | Nypydsqq | Rkns | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Wrzxklgl | Fplm | $12.5 Bil | |
CTLT
| Catalent Inc | Ftwkhlcm | Mlzcbkq | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Tsnxbtc | Pcpb | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Yhhmxhlm | Swqx | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fyjxtsss | Kbpgy | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Xyxpmvmm | Tlrs | $2.9 Bil |